US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 1.180
  • +0.080+7.27%
Close Feb 18 16:00 ET
  • 1.180
  • 0.0000.00%
Post 16:38 ET
62.24MMarket Cap-0.40P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALX Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

ALX Oncology Earnings Reports

  • ALX Oncology | 8-K: ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 7, 2024 16:11 ET

  • ALX Oncology | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:09 ET

  • ALX Oncology | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 16:08 ET

  • ALX Oncology | 8-K: ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 8, 2024 16:15 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +4.34%
    Constellation Brands
    STZ
    +3.95%
    New Fortress Energy
    NFE
    +3.79%
    Workday
    WDAY
    +2.97%
    Enerpac Tool
    EPAC
    +1.82%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 31, 2025

    Buy

    • Buy

      40.00%

    • Hold

      60.00%

    • Sell

      0.00%

    Price Target

    No Data